Home » Novartis, Penn Unite on New Anticancer Path
Novartis, Penn Unite on New Anticancer Path
The drugmaker Novartis and the University of Pennsylvania announced a research and licensing agreement early Monday that aims to bring to market a new approach to fighting cancer that has shown promising results in early trials.
The New York Times
The New York Times
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May